Researchers in the University of Minnesota College of Science and Engineering have developed a unique new device using the wonder material graphene that provides the first step toward ultrasensitive biosensors to detect diseases at the molecular level with near perfect efficiency.
Ultrasensitive biosensors for probing protein structures could greatly improve the depth of diagnosis for a wide variety of diseases extending to both humans and animals. These include Alzheimer’s disease, Chronic Wasting Disease, and mad cow disease—disorders related to protein misfolding. Such biosensors could also lead to improved technologies for developing new pharmaceutical compounds.
The research is published in Nature Nanotechnology, a peer-reviewed scientific journal published by Nature Publishing Group.
“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said Sang-Hyun Oh, University of Minnesota electrical and computer engineering professor and lead researcher on the study. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges.”
Graphene, a material made of a single layer of carbon atoms, was discovered more than a decade ago. It has enthralled researchers with its range of amazing properties that have found uses in many new applications, including creating better sensors for detecting diseases.
Significant attempts have been made to improve biosensors using graphene, but the challenge exists with its remarkable single atom thickness. This means it does not interact efficiently with light when shined through it. Light absorption and conversion to local electric fields is essential for detecting small amounts of molecules when diagnosing diseases. Previous research utilizing similar graphene nanostructures has only demonstrated a light absorption rate of less than 10 percent.
In this new study, University of Minnesota researchers combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique developed at the University of Minnesota, called “template stripping,” researchers were able to create an ultra-flat base layer surface for the graphene.
They then used the energy of light to generate a sloshing motion of electrons in the graphene, called plasmons, which can be thought to be like ripples or waves spreading through a “sea” of electrons. Similarly, these waves can build in intensity to giant “tidal waves” of local electric fields based on the researchers’ clever design.
By shining light on the single-atom-thick graphene layer device, they were able to create a plasmon wave with unprecedented efficiency at a near-perfect 94 percent light absorption into “tidal waves” of electric field. When they inserted protein molecules between the graphene and metal ribbons, they were able to harness enough energy to view single layers of protein molecules.
“Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94 percent light absorption in real devices,” said Oh, who holds the Sanford P. Bordeau Chair in Electrical Engineering at the University of Minnesota. “Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”
Learn more: Research Brief: New graphene-based device is first step toward ultrasensitive biosensors
The Latest on: Biosensors
[google_news title=”” keyword=”biosensors” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biosensors
- Three McCormick Faculty Elected to American Academy of Arts and Scienceson April 26, 2024 at 10:09 am
Wei Chen, Mark C. Hersam, and Uri J. Wilensky are among the 250 members elected in 2024, and six from the University. They are recognized for their excellence and commitment to uphold the Academy’s ...
- EQS-News: XTPL records all-time high revenues, Strategy execution remains on trackon April 26, 2024 at 12:06 am
Issuer: XTPL S.A. / Key word (s): Annual Results XTPL records all-time high revenues, Strategy execution remains on track 26.04.2024 / 07:30 CET/CEST The issuer is solely responsible for the ...
- The UW’s Institute for Protein Design keeps boosting startups, fueling AI-powered scienceon April 25, 2024 at 11:28 am
On Tuesday the latest venture based on IPD technology emerged: Xaira, a San-Francisco area startup co-founded by IPD head David Baker, backed with more than $1 billion from investors including Arch ...
- The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition Activity to Develop Wearable Biosensorson April 24, 2024 at 5:32 pm
The proposed sensor has the potential to not only revolutionize COPD management but also to impact healthcare by incorporating wearable electronics into chronic disease management Dr. Harry Rossiter, ...
- AI is boosting drug discovery and development — and sparking questions about proprietary dataon April 23, 2024 at 1:51 pm
AI and Biotech panel at Life Science Innovation Northwest 2024. From left: Danielle Greenawalt, Lynda Stuart, Sean McClain, Jonathan Cohen and moderator ...
- Biosensors Market Growth Foreseen To Achieve USD 63.07 Billion Value By 2032, With An Estimated 9% CAGRon April 19, 2024 at 7:15 am
According to Market.us, the global biosensors market is projected to expand significantly, reaching an estimated value of approximately USD 63 billion by 2032, up from USD 27.2 billion in 2022. This ...
- Affinity Biosensors of Santa Barbara receives FDA approval of LifeScale AST testing deviceon April 5, 2024 at 1:45 am
SANTA BARBARA, Calif. – Affinity Biosensors of Santa Barbara announced Wednesday that the diagnostic company's LifeScale AST system has received clearance from the U.S. Food and Drug Administration.
- Affinity Biosensors Receives FDA Clearance for the LifeScale AST Systemon April 4, 2024 at 7:53 am
S ANTA BARBARA, Calif., April 3, 2024 /PRNewswire/ -- Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has ...
- Flexible, Thin-Film Biosensorson December 27, 2022 at 8:06 pm
We like to keep a pulse on the latest biosensor research going on around the world. One class of biosensors that have really caught our attention is the so-called thin-film sensors, pioneered by ...
- Digital Biosensors and the Internet of Biologyon April 10, 2019 at 12:00 pm
The low power and reagent usage of these biosensors enables biotech engineers to gain immediate control over precise biological and environmental data. Learning Objectives: 1. Understand how ...
via Bing News